Literature DB >> 22341973

Mutations in LOXHD1, a recessive-deafness locus, cause dominant late-onset Fuchs corneal dystrophy.

S Amer Riazuddin1, David S Parker, Elyse J McGlumphy, Edwin C Oh, Benjamin W Iliff, Thore Schmedt, Ula Jurkunas, Robert Schleif, Nicholas Katsanis, John D Gottsch.   

Abstract

Fuchs corneal dystrophy (FCD) is a genetic disorder of the corneal endothelium and is the most common cause of corneal transplantation in the United States. Previously, we mapped a late-onset FCD locus, FCD2, on chromosome 18q. Here, we present next-generation sequencing of all coding exons in the FCD2 critical interval in a multigenerational pedigree in which FCD segregates as an autosomal-dominant trait. We identified a missense change in LOXHD1, a gene causing progressive hearing loss in humans, as the sole variant capable of explaining the phenotype in this pedigree. We observed LOXHD1 mRNA in cultured human corneal endothelial cells, whereas antibody staining of both human and mouse corneas showed staining in the corneal epithelium and endothelium. Corneal sections of the original proband were stained for LOXHD1 and demonstrated a distinct increase in antibody punctate staining in the endothelium and Descemet membrane; punctate staining was absent from both normal corneas and FCD corneas negative for causal LOXHD1 mutations. Subsequent interrogation of a cohort of >200 sporadic affected individuals identified another 15 heterozygous missense mutations that were absent from >800 control chromosomes. Furthermore, in silico analyses predicted that these mutations reside on the surface of the protein and are likely to affect the protein's interface and protein-protein interactions. Finally, expression of the familial LOXHD1 mutant allele as well as two sporadic mutations in cells revealed prominent cytoplasmic aggregates reminiscent of the corneal phenotype. All together, our data implicate rare alleles in LOXHD1 in the pathogenesis of FCD and highlight how different mutations in the same locus can potentially produce diverse phenotypes. Copyright Â
© 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341973      PMCID: PMC3309196          DOI: 10.1016/j.ajhg.2012.01.013

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  Twilight zone of protein sequence alignments.

Authors:  B Rost
Journal:  Protein Eng       Date:  1999-02

2.  Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13.

Authors:  Olof H Sundin; Albert S Jun; Karl W Broman; Sammy H Liu; Siobhan E Sheehan; Elizabeth C L Vito; Walter J Stark; John D Gottsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

3.  Clinical profile and early surgical complications in the Cornea Donor Study.

Authors:  Mark J Mannis; Edward J Holland; Roy W Beck; Michael W Belin; Marc A Goldberg; Robin L Gal; Andrea D Kalajian; Kenneth R Kenyon; Craig Kollman; Katrina J Ruedy; Patricia Smith; Joel Sugar; Walter J Stark
Journal:  Cornea       Date:  2006-02       Impact factor: 2.651

Review 4.  Myofibrillar myopathies: a clinical and myopathological guide.

Authors:  Rolf Schröder; Benedikt Schoser
Journal:  Brain Pathol       Date:  2009-07       Impact factor: 6.508

5.  Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy.

Authors:  S Biswas; F L Munier; J Yardley; N Hart-Holden; R Perveen; P Cousin; J E Sutphin; B Noble; M Batterbury; C Kielty; A Hackett; R Bonshek; A Ridgway; D McLeod; V C Sheffield; E M Stone; D F Schorderet; G C Black
Journal:  Hum Mol Genet       Date:  2001-10-01       Impact factor: 6.150

6.  Central cornea guttata. Incidence in the general population.

Authors:  D W Lorenzetti; M H Uotila; N Parikh; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

7.  Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2).

Authors:  Eranga N Vithana; Patricio Morgan; Periasamy Sundaresan; Neil D Ebenezer; Donald T H Tan; Moin D Mohamed; Seema Anand; Khin O Khine; Divya Venkataraman; Victor H K Yong; Manuel Salto-Tellez; Anandalakshmi Venkatraman; Ke Guo; Boomiraj Hemadevi; Muthiah Srinivasan; Venkatesh Prajna; Myint Khine; Joseph R Casey; Chris F Inglehearn; Tin Aung
Journal:  Nat Genet       Date:  2006-06-11       Impact factor: 38.330

8.  E2-2 protein and Fuchs's corneal dystrophy.

Authors:  Keith H Baratz; Nirubol Tosakulwong; Euijung Ryu; William L Brown; Kari Branham; Wei Chen; Khoa D Tran; Katharina E Schmid-Kubista; John R Heckenlively; Anand Swaroop; Goncalo Abecasis; Kent R Bailey; Albert O Edwards
Journal:  N Engl J Med       Date:  2010-08-25       Impact factor: 91.245

9.  SLC4A11 mutations in Fuchs endothelial corneal dystrophy.

Authors:  Eranga N Vithana; Patricio E Morgan; Vedam Ramprasad; Donald T H Tan; Victor H K Yong; Divya Venkataraman; Anandalakshmi Venkatraman; Gary H F Yam; Soumittra Nagasamy; Ricky W K Law; Rama Rajagopal; Chi P Pang; Govindsamy Kumaramanickevel; Joseph R Casey; Tin Aung
Journal:  Hum Mol Genet       Date:  2007-11-16       Impact factor: 6.150

10.  Hearing disability in patients with Fuchs' endothelial corneal dystrophy: unrecognized co-pathology?

Authors:  Marilette Stehouwer; Ward R Bijlsma; Allegonda Van der Lelij
Journal:  Clin Ophthalmol       Date:  2011-09-09
View more
  73 in total

1.  Mutations in AGBL1 cause dominant late-onset Fuchs corneal dystrophy and alter protein-protein interaction with TCF4.

Authors:  S Amer Riazuddin; Shivakumar Vasanth; Nicholas Katsanis; John D Gottsch
Journal:  Am J Hum Genet       Date:  2013-10-03       Impact factor: 11.025

Review 2.  The promise of whole-exome sequencing in medical genetics.

Authors:  Bahareh Rabbani; Mustafa Tekin; Nejat Mahdieh
Journal:  J Hum Genet       Date:  2013-11-07       Impact factor: 3.172

Review 3.  Biomechanical relationships between the corneal endothelium and Descemet's membrane.

Authors:  Maryam Ali; VijayKrishna Raghunathan; Jennifer Y Li; Christopher J Murphy; Sara M Thomasy
Journal:  Exp Eye Res       Date:  2016-09-14       Impact factor: 3.467

4.  TCF4 Triplet Repeat Expansion and Nuclear RNA Foci in Fuchs' Endothelial Corneal Dystrophy.

Authors:  V Vinod Mootha; Imran Hussain; Khrishen Cunnusamy; Eric Graham; Xin Gong; Sudha Neelam; Chao Xing; Ralf Kittler; W Matthew Petroll
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-26       Impact factor: 4.799

Review 5.  The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.

Authors:  Jie Zhang; Charles N J McGhee; Dipika V Patel
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

6.  Classification of posterior polymorphous corneal dystrophy as a corneal ectatic disorder following confirmation of associated significant corneal steepening.

Authors:  Anthony J Aldave; Lydia B Ann; Ricardo F Frausto; Catherine K Nguyen; Fei Yu; Irving M Raber
Journal:  JAMA Ophthalmol       Date:  2013-12       Impact factor: 7.389

7.  CTG18.1 Expansion in TCF4 Increases Likelihood of Transplantation in Fuchs Corneal Dystrophy.

Authors:  Allen O Eghrari; Shivakumar Vasanth; Jiangxia Wang; Farnoosh Vahedi; S Amer Riazuddin; John D Gottsch
Journal:  Cornea       Date:  2017-01       Impact factor: 2.651

8.  The genetics of Fuchs' corneal dystrophy.

Authors:  Benjamin W Iliff; S Amer Riazuddin; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2012-08

9.  Pilot Study of Audiometric Patterns in Fuchs Corneal Dystrophy.

Authors:  Nicholas S Reed; Jennifer A Deal; Matthew G Huddle; Joshua F Betz; Bethany E Bailey; Elyse J McGlumphy; Allen O Eghrari; S Amer Riazuddin; Frank R Lin; John D Gottsch
Journal:  J Speech Lang Hear Res       Date:  2018-10-26       Impact factor: 2.297

10.  Endothelial cell whole genome expression analysis in a mouse model of early-onset Fuchs' endothelial corneal dystrophy.

Authors:  Mario Matthaei; Jianfei Hu; Huan Meng; Eva-Maria Lackner; Charles G Eberhart; Jiang Qian; Haiping Hao; Albert S Jun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-15       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.